Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Stock and Capital in Excess of Par Value, Shares |
Common Stock and Capital in Excess of Par Value, Amount |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
| Beginning balance (in shares) at Jun. 30, 2024 |
|
134,425
|
|
|
|
| Beginning balance at Jun. 30, 2024 |
$ 3,368,328
|
|
$ 2,280,133
|
$ 1,137,270
|
$ (49,075)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
945,851
|
|
|
945,851
|
|
| Other comprehensive income (loss) |
23,571
|
|
|
|
23,571
|
| Net issuance under employee stock plans (in shares) |
|
134
|
|
|
|
| Net issuance under employee stock plans |
(72,245)
|
|
(72,245)
|
|
|
| Repurchase of common stock (in shares) |
|
(740)
|
|
|
|
| Repurchase of common stock |
(570,936)
|
|
(12,536)
|
(558,400)
|
|
| Cash dividends and dividend equivalents declared |
(196,555)
|
|
|
(196,555)
|
|
| Stock-based compensation expense |
61,700
|
|
61,700
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
133,819
|
|
|
|
| Ending balance at Sep. 30, 2024 |
3,559,714
|
|
2,257,052
|
1,328,166
|
(25,504)
|
| Beginning balance (in shares) at Jun. 30, 2024 |
|
134,425
|
|
|
|
| Beginning balance at Jun. 30, 2024 |
3,368,328
|
|
2,280,133
|
1,137,270
|
(49,075)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
2,858,794
|
|
|
|
|
| Other comprehensive income (loss) |
$ 6,442
|
|
|
|
|
| Repurchase of common stock (in shares) |
(2,430)
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
132,241
|
|
|
|
| Ending balance at Mar. 31, 2025 |
$ 4,004,739
|
|
2,401,317
|
1,646,055
|
(42,633)
|
| Beginning balance (in shares) at Sep. 30, 2024 |
|
133,819
|
|
|
|
| Beginning balance at Sep. 30, 2024 |
3,559,714
|
|
2,257,052
|
1,328,166
|
(25,504)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
824,527
|
|
|
824,527
|
|
| Other comprehensive income (loss) |
(20,882)
|
|
|
|
(20,882)
|
| Net issuance under employee stock plans (in shares) |
|
104
|
|
|
|
| Net issuance under employee stock plans |
43,931
|
|
43,931
|
|
|
| Repurchase of common stock (in shares) |
|
(979)
|
|
|
|
| Repurchase of common stock |
(655,973)
|
|
(16,478)
|
(639,495)
|
|
| Cash dividends and dividend equivalents declared |
(228,609)
|
|
|
(228,609)
|
|
| Stock-based compensation expense |
61,841
|
|
61,841
|
|
|
| Ending balance (in shares) at Dec. 31, 2024 |
|
132,944
|
|
|
|
| Ending balance at Dec. 31, 2024 |
3,584,549
|
|
2,346,346
|
1,284,589
|
(46,386)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
1,088,416
|
|
|
1,088,416
|
|
| Other comprehensive income (loss) |
3,753
|
|
|
|
3,753
|
| Net issuance under employee stock plans (in shares) |
|
8
|
|
|
|
| Net issuance under employee stock plans |
$ (2,680)
|
|
(2,680)
|
|
|
| Repurchase of common stock (in shares) |
(711)
|
(711)
|
|
|
|
| Repurchase of common stock |
$ (511,703)
|
|
(12,550)
|
(499,153)
|
|
| Cash dividends and dividend equivalents declared |
(227,797)
|
|
|
(227,797)
|
|
| Stock-based compensation expense |
70,201
|
|
70,201
|
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
132,241
|
|
|
|
| Ending balance at Mar. 31, 2025 |
4,004,739
|
|
2,401,317
|
1,646,055
|
(42,633)
|
| Beginning balance (in shares) at Jun. 30, 2025 |
|
132,023
|
|
|
|
| Beginning balance at Jun. 30, 2025 |
4,692,453
|
|
2,511,922
|
2,179,330
|
1,201
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
1,121,040
|
|
|
1,121,040
|
|
| Other comprehensive income (loss) |
(530)
|
|
|
|
(530)
|
| Net issuance under employee stock plans (in shares) |
|
116
|
|
|
|
| Net issuance under employee stock plans |
(81,122)
|
|
(81,122)
|
|
|
| Repurchase of common stock (in shares) |
|
(623)
|
|
|
|
| Repurchase of common stock |
(564,400)
|
|
(11,861)
|
(552,539)
|
|
| Cash dividends and dividend equivalents declared |
(252,552)
|
|
|
(252,552)
|
|
| Stock-based compensation expense |
70,182
|
|
70,182
|
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
|
131,516
|
|
|
|
| Ending balance at Sep. 30, 2025 |
4,985,071
|
|
2,489,121
|
2,495,279
|
671
|
| Beginning balance (in shares) at Jun. 30, 2025 |
|
132,023
|
|
|
|
| Beginning balance at Jun. 30, 2025 |
4,692,453
|
|
2,511,922
|
2,179,330
|
1,201
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
3,467,712
|
|
|
|
|
| Other comprehensive income (loss) |
$ (33,181)
|
|
|
|
|
| Repurchase of common stock (in shares) |
(1,523)
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
130,710
|
|
|
|
| Ending balance at Mar. 31, 2026 |
$ 5,830,495
|
|
2,675,013
|
3,187,462
|
(31,980)
|
| Beginning balance (in shares) at Sep. 30, 2025 |
|
131,516
|
|
|
|
| Beginning balance at Sep. 30, 2025 |
4,985,071
|
|
2,489,121
|
2,495,279
|
671
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
1,145,682
|
|
|
1,145,682
|
|
| Other comprehensive income (loss) |
289
|
|
|
|
289
|
| Net issuance under employee stock plans (in shares) |
|
87
|
|
|
|
| Net issuance under employee stock plans |
49,826
|
|
49,826
|
|
|
| Repurchase of common stock (in shares) |
|
(460)
|
|
|
|
| Repurchase of common stock |
(537,553)
|
|
(8,717)
|
(528,836)
|
|
| Cash dividends and dividend equivalents declared |
(251,531)
|
|
|
(251,531)
|
|
| Stock-based compensation expense |
73,947
|
|
73,947
|
|
|
| Ending balance (in shares) at Dec. 31, 2025 |
|
131,143
|
|
|
|
| Ending balance at Dec. 31, 2025 |
5,465,731
|
|
2,604,177
|
2,860,594
|
960
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net income |
1,200,990
|
|
|
1,200,990
|
|
| Other comprehensive income (loss) |
(32,940)
|
|
|
|
(32,940)
|
| Net issuance under employee stock plans (in shares) |
|
7
|
|
|
|
| Net issuance under employee stock plans |
$ (4,361)
|
|
(4,361)
|
|
|
| Repurchase of common stock (in shares) |
(440)
|
(440)
|
|
|
|
| Repurchase of common stock |
$ (631,913)
|
|
(8,741)
|
(623,172)
|
|
| Cash dividends and dividend equivalents declared |
(250,950)
|
|
|
(250,950)
|
|
| Stock-based compensation expense |
83,938
|
|
83,938
|
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
130,710
|
|
|
|
| Ending balance at Mar. 31, 2026 |
$ 5,830,495
|
|
$ 2,675,013
|
$ 3,187,462
|
$ (31,980)
|